Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty522008Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans532011Chief Financial Officer & Executive Director
Birgitte Volck MD, PhD552016Head-Research & Development
Moncef Slaoui, PhD562006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson692007Independent Non-Executive Director
Patrick J. T. Vallance, MD-2006Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Emma Walmsley-2010CEO-Designate & Executive Director
Lynn Laverty Elsenhans, MBA602012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,375,130,274 4,870,580,848 90.6% 458,205,950 8.5% 90.6%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 207,257,650 4.22%
Legal & General Investment Management Ltd. 147,931,457 3.01%
The Vanguard Group, Inc. 124,030,255 2.53%
Norges Bank Investment Management 93,938,000 1.91%
BlackRock Advisors (UK) Ltd. 87,446,994 1.78%
Capital Research & Management Co. (Global Investors) 87,118,304 1.77%
Woodford Investment Management LLP 70,574,150 1.44%
State Street Global Advisors Ltd. 65,016,180 1.32%
Threadneedle Asset Management Ltd. 58,888,549 1.20%
Schroder Investment Management Ltd. 55,182,404 1.12%
Holdings
NameEquities%Valuation
Innoviva Inc (INVA) 32,005,26029.4%369,660,753 USD
Theravance Biopharma Inc (TBPH) 9,644,80718.6%295,323,990 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%195,786,693 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.09%76,425,479 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%47,900,937 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.67%46,376,920 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5467.03%26,492,667 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,54137.1%19,885,255 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%3,273,578 USD
SCYNEXIS Inc (SCYX) 545,0062.27%1,798,520 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC5.96%102 400
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.73%219 545
PFIZER INC.4.68%202 474
NOVARTIS AG-0.94%195 096
MERCK & CO., INC.7.32%173 465
SANOFI7.76%115 582
GLAXOSMITHKLINE PLC6.95%102 400
BAYER AG7.94%95 518
ELI LILLY AND CO14.45%92 880
BRISTOL-MYERS SQUIBB C..-4.36%92 079
ALLERGAN PLC13.01%79 559
ASTRAZENECA PLC11.06%78 074
ABBOTT LABORATORIES16.45%77 293
NOVO NORDISK A/S-9.07%67 736
SHIRE PLC-0.16%52 993
TAKEDA PHARMACEUTICAL ..8.83%37 345
TEVA PHARMACEUTICAL IN..-12.65%33 487
ASTELLAS PHARMA INC-6.52%29 396
MYLAN NV7.37%21 934
CHUGAI PHARMACEUTICAL ..15.80%19 524
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Pearson Education Ltd.
Business Council for Britain
Pharmaceutical Research & Manufacturers of America
American Academy of Arts & Sciences
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
The 100 Group
The University of Nottingham
National Theatre of Scotland
Sunoco Chemicals, Inc.
TFS Trial Form Support AB
Central Houston, Inc.
Office for Strategic Co-ordination of Health Research
French Academy of Sciences
GlaxoSmithKline, Inc.
Genome Research Ltd.
Biotechnology Innovation Organization
Glaxosmithkline Australia Pty Ltd.
United Kingdom Department for Business, Innovation & Skills
Rockefeller Family Trust, Inc.
United Way of Greater Houston
Massachusetts Institute of Technology
World Golf Foundation, Inc.
Sunoco Partners LLC
International AIDS Vaccine Initiative, Inc.
PhRMA Foundation
Longwood Fund Management LLC
Rice University
The Natural History Museum
The Texas Medical Center
Institute of Medicine
The First Tee of Greater Houston
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem